Jenthera Therapeutics
PrivateLast Round
Grant
Jun 18, 2023
Total Funding Raised
$17,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Jenthera Therapeutics is a biotechnology company that develops in vivo CRISPR-based therapeutics using a proprietary non-viral delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jenthera Therapeutics Comparables
Compare Jenthera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cove Therapeutics, Inc. | 82% | |
| BreezeBio | 80% | |
| Ligandal, Inc. | 80% |
Jenthera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 18, 2023 | ||||
| Seed | Jul 1, 2020 | ||||
| Accelerator | Oct 21, 2019 |
Jenthera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beresford Ventures | Seed |
| adMare BioInnovations | Seed |
| Illumina Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 33% MoM.
- Jul 27, 2026
Monthly visitors grew 177% MoM.
Jenthera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Jenthera Therapeutics's valuation, stock price, and market status.
Is Jenthera Therapeutics a public or private company?
Jenthera Therapeutics is a private company.
What is the current stock price of Jenthera Therapeutics?
Jenthera Therapeutics is a private company, so its shares have no public market price. Caplight tracks Jenthera Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jenthera Therapeutics worth (valuation)?
Valuation information for Jenthera Therapeutics is not publicly available.
Can I buy Jenthera Therapeutics stock?
Jenthera Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jenthera Therapeutics's last funding round?
Jenthera Therapeutics's most recent funding round was Grant on June 18, 2023.
Who are the main investors in Jenthera Therapeutics?
Key investors in Jenthera Therapeutics include Beresford Ventures, adMare BioInnovations, Illumina Accelerator.
Will Jenthera Therapeutics IPO soon?
No public IPO plans have been announced for Jenthera Therapeutics.
How can I track Jenthera Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Jenthera Therapeutics's shares on secondary markets.